Summary: WELL Health Technologies Corp.

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Highlights: WELL Health Technologies Corp.

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses: WELL Health Technologies Corp.

  • The company sustains low margins.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings Chart: WELL Health Technologies Corp.

Source: Surperformance

ESG chart: WELL Health Technologies Corp.

Source: MSCI

Fundamentals (Composite) Global Valuation (Composite) Financial estimates revisions (Composite) Capi.($)
- - 864M
- 90.47B
81.95B
27.63B
24.73B
20.89B
18.76B
16.32B
15.87B
13.82B
Average 31.13B
Weighted average by Cap.
See all sector ratings
Investor (Composite)
-
Trader (Composite)
ESG MSCI
A

Financials

Revenue growth
EPS growth
Capital Efficiency (Composite)
-
Net Margin
Financial Health (Composite)
-

Valuation

P/E
EV/Revenue
EV/EBITDA
PBR
-
Dividend Yield
-

Revisions

Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)

Business Predictability

Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence

ESG

Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. WELL Stock
  4. Ratings WELL Health Technologies Corp.